Limits on medicare's ability to control rising spending on cancer drugs Journal Article
| Author: | Bach, P. B. |
| Article Title: | Limits on medicare's ability to control rising spending on cancer drugs |
| Abstract: | During the past decade, the price of cancer drugs and the spending for cancer treatments by Medicare have increased dramatically. The author outlines the usual tools Medicare uses to control its spending on drugs and discusses the policies that make cancer drugs a special case and prohibit the regulation of their prices and utilization Copyright © 2009 Massachusetts Medical Society. |
| Keywords: | review; antineoplastic agents; united states; paclitaxel; antineoplastic agent; practice guideline; food and drug administration; cancer therapy; health care policy; goserelin; ipratropium bromide plus salbutamol sulfate; leuprorelin; levalbuterol; salbutamol; cost control; cost effectiveness analysis; drug cost; financial management; health care; health care cost; health care utilization; health economics; health insurance; health program; health service; law; medicaid; medical instrumentation; medicare; prescription; reimbursement; economics; government; legal aspect; drug costs; health expenditures; health policy; reimbursement mechanisms; state government |
| Journal Title: | New England Journal of Medicine |
| Volume: | 360 |
| Issue: | 6 |
| ISSN: | 0028-4793 |
| Publisher: | Massachusetts Medical Society |
| Date Published: | 2009-02-05 |
| Start Page: | 626 |
| End Page: | 633+562 |
| Language: | English |
| PUBMED: | 19176475 |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | --- - "Cited By (since 1996): 24" - "Export Date: 30 November 2010" - "CODEN: NEJMA" - "Source: Scopus" |
